Bioresponsive Immunotherapeutic Materials
Authors:
- 20 April 2023
- journal article
- review article
- Published by Wiley in Advanced Materials
- Vol. 36 (43) , e2209778
Abstract
The human immune system is an interaction network of biological processes, and its dysfunction is closely associated with a wide array of diseases, such as cancer, infectious diseases, tissue damage, and autoimmune diseases. Manipulation of the immune response network in a desired and controlled fashion has been regarded as a promising strategy for maximizing immunotherapeutic efficacy and minimizing side effects. Integration of “smart” bioresponsive materials with immunoactive agents including small molecules, biomacromolecules, and cells can achieve on‐demand release of agents at targeted sites to reduce overdose‐related toxicity and alleviate off‐target effects. This review highlights the design principles of bioresponsive immunotherapeutic materials and discusses the critical roles of controlled release of immunoactive agents from bioresponsive materials in recruiting, housing, and manipulating immune cells for evoking desired immune responses. Challenges and future directions from the perspective of clinical translation are also discussed.Keywords
Funding Information
- National Natural Science Foundation of China (52233013, 32271380)
- Juvenile Diabetes Research Foundation International (2‐SRA‐2021‐1064‐M‐B)
This publication has 283 references indexed in Scilit:
- A Spatially-Organized Multicellular Innate Immune Response in Lymph Nodes Limits Systemic Pathogen SpreadCell, 2012
- Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardiumBiomaterials, 2011
- Programming the magnitude and persistence of antibody responses with innate immunityNature, 2011
- Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responsesNature Materials, 2011
- Recognition of herpesviruses by the innate immune systemNature Reviews Immunology, 2011
- Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestinesNature Materials, 2010
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Construction of Bacteriophage Phi29 DNA Packaging Motor and its Applications in Nanotechnology and TherapyAnnals of Biomedical Engineering, 2009
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002